Literature DB >> 15826805

Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells.

Mark A Tirmenstein1, Catherine X Hu, Marshall S Scicchitano, Padma K Narayanan, David C McFarland, Heath C Thomas, Lester W Schwartz.   

Abstract

SH-SY5Y human neuroblastoma cells were incubated with 6-hydroxydopamine (6-OHDA) for 4 and 24 h to examine the mechanism of cell death and to determine the time-dependent effects of 6-OHDA on cellular glutathione status. After 4 h, 6-OHDA significantly depleted cellular ATP and GSH concentrations with only slight increases in cell death. GSH:GSSG ratios and mitochondrial membrane potential (Deltapsim) were significantly decreased during 4 h incubations with 6-OHDA. High concentrations of 6-OHDA (100 microM) induced oxidative stress and mitochondrial dysfunction in SH-SY5Y cells within 4 h leading to cell death. In 24 h incubations, 25 and 50 microM 6-OHDA significantly decreased ATP concentrations; however, significant increases in cell death were only observed with 50 microM 6-OHDA. 6-OHDA induced a concentration-dependent increase in GSH and total glutathione concentrations after 24 h. After exposure to 50 microM 6-OHDA, GSH concentrations were increased up to 12-fold after 24 h with no change in the GSH:GSSG ratio. Gene analysis suggests that the increase in GSH concentration was due to increased expression of the GSH synthesis genes glutamate cysteine ligase modifier and catalytic subunits. Our results suggest that 6-OHDA induces oxidative stress in SH-SY5Y cells resulting in an adaptive increase in cellular GSH concentrations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15826805     DOI: 10.1016/j.tiv.2005.01.006

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  17 in total

1.  The hydrolysis of striatal adenine- and guanine-based purines in a 6-hydroxydopamine rat model of Parkinson's disease.

Authors:  Jean Pierre Oses; Cristiane Batassini; Daniela Pochmann; Ana Elisa Böhmer; Fernanda Cenci Vuaden; Roberta Bristot Silvestrin; Alcyr Oliveira; Carla Denise Bonan; Maurício Reis Bogo; Diogo Onofre Souza; Luis Valmor Cruz Portela; João José de Freitas Sarkis; Tadeu Mello e Souza
Journal:  Neurochem Res       Date:  2010-11-04       Impact factor: 3.996

2.  Dopamine as a potent inducer of cellular glutathione and NAD(P)H:quinone oxidoreductase 1 in PC12 neuronal cells: a potential adaptive mechanism for dopaminergic neuroprotection.

Authors:  Zhenquan Jia; Hong Zhu; Bhaba R Misra; Yunbo Li; Hara P Misra
Journal:  Neurochem Res       Date:  2008-03-27       Impact factor: 3.996

3.  3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder.

Authors:  Ana Cristina Andreazza; Flavio Kapczinski; Marcia Kauer-Sant'Anna; Julio C Walz; David J Bond; Carlos A Gonçalves; L Trevor Young; Lakshmi N Yatham
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

4.  Myricitrin alleviates methylglyoxal-induced mitochondrial dysfunction and AGEs/RAGE/NF-κB pathway activation in SH-SY5Y cells.

Authors:  Yue-Hua Wang; Hai-Tao Yu; Xiao-Ping Pu; Guan-Hua Du
Journal:  J Mol Neurosci       Date:  2014-02-09       Impact factor: 3.444

5.  Deletion of the Creatine Transporter (Slc6a8) in Dopaminergic Neurons Leads to Hyperactivity in Mice.

Authors:  Zuhair I Abdulla; Bahar Pahlevani; Kerstin H Lundgren; Jordan L Pennington; Kenea C Udobi; Kim B Seroogy; Matthew R Skelton
Journal:  J Mol Neurosci       Date:  2019-09-13       Impact factor: 3.444

6.  6-Hydroxydopamine induces mitochondrial ERK activation.

Authors:  Scott M Kulich; Craig Horbinski; Manisha Patel; Charleen T Chu
Journal:  Free Radic Biol Med       Date:  2007-04-29       Impact factor: 7.376

7.  Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model.

Authors:  Mauricio Peña Cunha; Maria D Martín-de-Saavedra; Alejandro Romero; Javier Egea; Fabiana K Ludka; Carla I Tasca; Marcelo Farina; Ana Lúcia S Rodrigues; Manuela G López
Journal:  ASN Neuro       Date:  2014-11-24       Impact factor: 4.146

8.  Echinacoside Protects against 6-Hydroxydopamine-Induced Mitochondrial Dysfunction and Inflammatory Responses in PC12 Cells via Reducing ROS Production.

Authors:  Yue-Hua Wang; Zhao-Hong Xuan; Shuo Tian; Guan-Hua Du
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-18       Impact factor: 2.629

9.  Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.

Authors:  Brendan D Looyenga; James Resau; Jeffrey P MacKeigan
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  The Cytomegalovirus protein pUL37×1 targets mitochondria to mediate neuroprotection.

Authors:  Chien Tai Hong; Kai-Yin Chau; Anthony H V Schapira
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.